Cargando…
An evaluation of the sonoporation potential of low-boiling point phase-change ultrasound contrast agents in vitro
BACKGROUND: Phase-change ultrasound contrast agents (PCCAs) offer a solution to the inherent limitations associated with using microbubbles for sonoporation; they are characterized by prolonged circulation lifetimes, and their nanometer-scale sizes may allow for passive accumulation in solid tumors....
Autores principales: | Fix, Samantha M., Novell, Anthony, Yun, Yeoheung, Dayton, Paul A., Arena, Christopher B. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2017
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5260003/ https://www.ncbi.nlm.nih.gov/pubmed/28127427 http://dx.doi.org/10.1186/s40349-017-0085-z |
Ejemplares similares
-
Low‐boiling Point Perfluorocarbon Nanodroplets as Dual‐Phase Dual‐Modality MR/US Contrast Agent
por: McHugh, Christian T., et al.
Publicado: (2022) -
Transient acoustic vaporization signatures unique to low boiling point phase change contrast agents enable super-resolution ultrasound imaging without spatiotemporal filtering
por: DeRuiter, R. M., et al.
Publicado: (2020) -
In vitro parameter optimization for spatial control of focused ultrasound ablation when using low boiling point phase-change nanoemulsions
por: Puett, Connor, et al.
Publicado: (2013) -
Sonoporation by low-frequency and low-power ultrasound enhances chemotherapeutic efficacy in prostate cancer cells in vitro
por: WANG, YU, et al.
Publicado: (2013) -
Landscape of Cellular Bioeffects Triggered by Ultrasound-Induced Sonoporation
por: Przystupski, Dawid, et al.
Publicado: (2022)